Discovering anti-osteoporosis constituents of maca (Lepidium meyenii) by combined virtual screening and activity verification

Food Research International

Volumn 77, Issue , 2015, Pages 215-220

  Liu, Hao ^a   Jin, Wenwen ^a,b,c   Fu, Chunhua ^a,b   Dai, Penfei ^a,c   Yu, Yuantao ^a,c   Huo, Qin ^a   Yu, Longjiang ^a,b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Wuhan Institute of Biotechnology   (China)

Author keywords

Activity verification; Lepidium meyenii; Macamide; Osteoporosis; Virtual screening

Indexed keywords

BIOACTIVITY; BONE; DIAGNOSIS; GENE EXPRESSION; GENES; OSTEOBLASTS; PHOSPHATASES;

BONE MORPHOGENETIC PROTEIN-2; LEPIDIUM MEYENII; MACAMIDE; OSTEOBLAST PROLIFERATION; OSTEOGENESIS-RELATED GENES; OSTEOPOROSIS; PHARMACOLOGICAL ACTIVITY; VIRTUAL SCREENING;

DISEASES;

EID: 84947041989     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2015.06.028     Document Type: Article

References (55)

1. Bab I., Zimmer A. Cannabinoid receptors and the regulation of bone mass. British Journal of Pharmacology 2008, 153(2):182-188.
2. Becker D.J., Kilgore M.L., Morrisey M.A. The societal burden of osteoporosis. Current Rheumatology Reports 2010, 12(3):186-191.
3. Bord S., Ireland D.C., Beavan S.R., Compston J.E. The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 2003, 32(2):136-141.
4. Brooks N.A., Wilcox G., Walker K.Z., Ashton J.F., Cox M.B., Stojanovska L. Beneficial effects of Lepidium meyenii (maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content. Menopause-The Journal of the North American Menopause Society 2008, 15(6):1157-1162.
5. Choi E.M. Magnolol protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity through activation of mitochondrial function. Inflammation 2012, 35(3):1204-1212.
6. Clément C., Diaz D., Manrique I., Avula B., Khan I.A., Ponce Aguirre D.D., et al. Secondary metabolites in maca as affected by hypocotyl color, cultivation history, and site. Agronomy Journal 2010, 102(2):431-439.
7. Cui B., Zheng B.L., He K., Zheng Q.Y. Imidazole alkaloids from Lepidium meyenii. Journal of Natural Products 2003, 66(8):1101-1103.
8. DiGirolamo D.J., Mukherjee A., Fulzele K., Gan Y., Cao X., Frank S.J., et al. Mode of growth hormone action in osteoblasts. Journal of Biological Chemistry 2007, 282(43):31666-31674.
9. Ewing T.J., Makino S., Skillman A.G., Kuntz I.D. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases. Journal of Computer-Aided Molecular Design 2001, 15(5):411-428.
10. Farina E.K., Kiel D.P., Roubenoff R., Schaefer E.J., Cupples L.A., Tucker K.L. Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: The Framingham Osteoporosis Study. American Journal of Clinical Nutrition 2011, 93(5):1142-1151.
11. Gonzales G.F. Ethnobiology and ethnopharmacology of Lepidium meyenii (maca), a plant from the Peruvian highlands. Evidence-based Complementary and Alternative Medicine 2012, 18(1):72-79.
12. Gonzales C., Cárdenas-Valencia I., Leiva-Revilla J., Anza-Ramirez C., Rubio J., Gonzales G.F. Effects of different varieties of maca (Lepidium meyenii) on bone structure in ovariectomized rats. Forschende Komplementärmedizin 2010, 17(3):137-143.
13. Gonzales G.F., Cordova A., Vega K., Chung A., Villena A., Gonez C. Effect of Lepidium meyenii (maca), a root with aphrodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men. Journal of Endocrinology 2003, 176(1):163-168.
14. Hajdu Z., Nicolussi S., Rau M., Lorántfy L., Forgo P., Hohmann J., et al. Identification of endocannabinoid system-modulating N-alkylamides from Heliopsis helianthoides var. scabra and Lepidium meyenii. Journal of Natural Products 2014, 77(7):1663-1669.
15. Harvey N., Dennison E., Cooper C. Osteoporosis: A lifecourse approach. Journal of Bone and Mineral Research 2014, 29(9):1917-1925.
16. Hermann A.P., Abrahamsen B. The bisphosphonates: Risks and benefits of long term use. Current Opinion in Pharmacology 2013, 13(3):435-439.
17. Idris A.I., Ralston S.H. Role of cannabinoids in the regulation of bone remodeling. Frontiers in Endocrinology 2012, 3:136.
18. Janssens K., Ten Dijke P., Janssens S., Van Hul W. Transforming growth factor-beta1 to the bone. Endocrine Reviews 2005, 26(6):743-774.
19. Jilka R.L., O'Brien C.A., Ali A.A., Roberson P.K., Weinstein R.S., Manolagas S.C. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone 2009, 44(2):275-286.
20. Jones G., Willett P., Glen R.C., Leach A.R., Taylor R. Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology 1997, 267(3):727-748.
21. Kitchen D.B., Decornez H., Furr J.R., Bajorath J. Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature Reviews Drug Discovery 2004, 3(11):935-949.
22. Kono R., Okuno Y., Inada K., Tokuda A., Hashizume H., Yoshida M., et al. A Prunus mume extract stimulated the proliferation and differentiation of osteoblastic MC3T3-E1 Cells. Bioscience, Biotechnology, and Biochemistry 2011, 75(10):1907-1911.
23. Krane S.M. Identifying genes that regulate bone remodeling as potential therapeutic targets. Journal of Experimental Medicine 2005, 201(6):841-843.
24. Lee M.S., Shin B., Yang E.J., Lim H., Ernst E. Maca (Lepidium meyenii) for treatment of menopausal symptoms: A systematic review. Maturitas 2011, 70(3):227-233.
25. Li G., Ammermann U., Quirós C.F. Glucosinolate contents in maca (Lepidium peruvianum Chacón) seeds, sprouts, mature plants and several derived commercial products. Economic Botany 2001, 55(2):255-262.
26. Lorand T., Vigh E., Garai J. Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: Phytoestrogens and xenoestrogens. Current Medicinal Chemistry 2010, 17(30):3542-3574.
27. McCollom M.M., Villinski J.R., McPhail K.L., Craker L.E., Gafner S. Analysis of macamides in samples of maca (Lepidium meyenii) by HPLC-UV-MS/MS. Phytochemical Analysis 2005, 16(6):463-469.
28. Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry 2009, 30(16):2785-2791.
29. Muhammad I., Zhao J., Dunbar D.C., Khan I.A. Constituents of Lepidium meyenii 'maca'. Phytochemistry 2002, 59(1):105-110.
30. Nelson E.R., Wardell S.E., McDonnell D.P. The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: Implications for the treatment and prevention of osteoporosis. Bone 2013, 53(1):42-50.
31. Okamoto M., Murai J., Yoshikawa H., Tsumaki N. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. Journal of Bone and Mineral Research 2006, 21(7):1022-1033.
32. Poluzzi E., Piccinni C., Raschi E., Rampa A., Recanatini M., De Ponti F. Phytoestrogens in postmenopause: The state of the art from a chemical, pharmacological and regulatory perspective. Current Medicinal Chemistry 2014, 21(4):417-436.
33. Pomatto V., Palermo F., Mosconi G., Cottone E., Cocci P., Nabissi M., et al. Xenoestrogens elicit a modulation of endocannabinoid system and estrogen receptors in 4NP treated goldfish, Carassius auratus. General and Comparative Endocrinology 2011, 174(1):30-35.
34. Rarey M., Kramer B., Lengauer T., Klebe G. A fast flexible docking method using an incremental construction algorithm. Journal of Molecular Biology 1996, 261(3):470-489.
35. Reid I.R. Osteoporosis treatment: Focus on safety. European Journal of Internal Medicine 2013, 24(8):691-697.
36. Rodan G.A. Therapeutic approaches to bone diseases. Science 2000, 289(5484):1508-1514.
37. Rollinger J.M., Bodensieck A., Seger C., Ellmerer E.P., Bauer R., Langer T., et al. Discovering cox-inhibiting constituents of Morus root bark: Activity-guided versus computer-aided methods. Planta Medica 2005, 71(5):399-405.
38. Rossi F., Bellini G., Luongo L., Torella M., Mancusi S., De Petrocellis L., et al. The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy. Bone 2011, 48(5):997-1007.
39. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial. JAMA-Journal of the American Medical Association 2002, 288(3):321-333.
40. Sharma P.K., Thakur M.K. Expression of estrogen receptor (ER) alpha and beta in mouse cerebral cortex: Effect of age, sex and gonadal steroids. Neurobiology of Aging 2006, 27(6):880-887.
41. Shen C.L., Wang P., Guerrieri J., Yeh J.K., Wang J.S. Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporosis International 2008, 19(7):979-990.
42. Shoichet B.K. Virtual screening of chemical libraries. Nature 2004, 432(7019):862-865.
43. Tella S.H., Gallagher J.C. Prevention and treatment of postmenopausal osteoporosis. The Journal of Steroid Biochemistry and Molecular Biology 2014, 142(SI):155-170.
44. Thakur M.K., Sharma P.K. Transcription of estrogen receptor alpha and beta in mouse cerebral cortex: effect of age, sex, 17-beta-estradiol and testosterone. Neurochemistry International 2007, 50(2):314-321.
45. Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry 2009, 31(2):455-461.
46. Uchiyama F., Jikyo T., Takeda R., Ogata M. Lepidium meyenii (maca) enhances the serum levels of luteinising hormone in female rats. Journal of Ethnopharmacology 2014, 151(2):897-902.
47. Vajdos F.F., Hoth L.R., Geoghegan K.F., Simons S.P., LeMotte P.K., Danley D.E., et al. The 2.0Å crystal structure of the ERα ligand-binding domain complexed with lasofoxifene. Protein Science 2007, 16(5):897-905.
48. Valentová K., Buckiová D., Křen V., Pěknicová J., Ulrichová J., Šimánek V. The in vitro biological activity of Lepidium meyenii extracts. Cell Biology and Toxicology 2006, 22(2):91-99.
49. Viereck V., Siggelkow H., Tauber S., Raddatz D., Schutze N., HüFner M. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts. Journal of Cellular Biochemistry 2002, 86(2):348-356.
50. Warnmark A. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha. Journal of Biological Chemistry 2002, 277(24):21862-21868.
51. Wu H., Kelley C.J., Pino-Figueroa A., Vu H.D., Maher T.J. Macamides and their synthetic analogs: Evaluation of in vitro FAAH inhibition. Bioorganic & Medicinal Chemistry 2013, 21(17):5188-5197.
52. Zhang M., Xuan S., Bouxsein M.L., von Stechow D., Akeno N., Faugere M.C., et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. Journal of Biological Chemistry 2002, 277(46):44005-44012.
53. Zhang Y., Yu L., Ao M., Jin W. Effect of ethanol extract of Lepidium meyenii Walp. on osteoporosis in ovariectomized rat. Journal of Ethnopharmacology 2006, 105(1-2):274-279.
54. Zhang Y., Yu L., Jin W., Ao M. Effect of ethanolic extract of Lepidium meyenii Walp on serum hormone levels in ovariectomized rats. Indian Journal of Pharmacology 2014, 46(4):416-419.
55. Zhou H., Mak W., Kalak R., Street J., Fong-Yee C., Zheng Y., et al. Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice. Development 2009, 136(3):427-436.